カテゴリー： LP Information, 世界, 部品/材料

世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年

【英語タイトル】Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY0712）・商品コード：LPI21MY0712
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：164
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「解熱鎮痛薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、頭痛・発熱、風邪・咳、筋肉痙攣、その他などにセグメント区分してまとめました。解熱鎮痛薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・解熱鎮痛薬用有効成分の世界市場概要（サマリー）
・解熱鎮痛薬用有効成分の企業別販売量・売上
・解熱鎮痛薬用有効成分の企業別市場シェア
・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他）
・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他）
・解熱鎮痛薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・解熱鎮痛薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・解熱鎮痛薬用有効成分のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・解熱鎮痛薬用有効成分の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・解熱鎮痛薬用有効成分市場の成長要因・課題・動向
・解熱鎮痛薬用有効成分の世界市場予測 2021年-2026年
・解熱鎮痛薬用有効成分の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・解熱鎮痛薬用有効成分のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・解熱鎮痛薬用有効成分のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・解熱鎮痛薬用有効成分の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・解熱鎮痛薬用有効成分の世界市場予測：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他）
・解熱鎮痛薬用有効成分の世界市場予測：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Antipyretic Analgesic Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesic Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antipyretic Analgesic Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesic Active Pharmaceutical Ingredients market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Headache and Fever
Cold and Cough
Muscle Cramps
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Jingye Group
Hunan Zhongnan Pharmaceutical

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Consumption 2016-2026
2.1.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Consumption CAGR by Region
2.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Segment by Type
2.2.1 Paracetamol
2.2.2 Aspirin
2.2.3 Ibuprofen
2.2.4 Naproxen
2.2.5 Diclofenac
2.2.6 Oxaprozin
2.2.7 Dexibuprofen
2.2.8 Others
2.3 Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type
2.3.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
2.3.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Type (2016-2021)
2.4 Antipyretic Analgesic Active Pharmaceutical Ingredients Segment by Application
2.4.1 Headache and Fever
2.4.2 Cold and Cough
2.4.3 Muscle Cramps
2.4.4 Others
2.5 Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application
2.5.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Market Share by Application (2016-2021)
2.5.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Application (2016-2021)

3 Global Antipyretic Analgesic Active Pharmaceutical Ingredients by Company
3.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Company
3.1.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Company (2019-2021)
3.1.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Company (2019-2021)
3.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Company
3.2.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Company (2019-2021)
3.2.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Company (2019-2021)
3.3 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Company
3.4 Global Manufacturers Antipyretic Analgesic Active Pharmaceutical Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antipyretic Analgesic Active Pharmaceutical Ingredients Product Location Distribution
3.4.2 Players Antipyretic Analgesic Active Pharmaceutical Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antipyretic Analgesic Active Pharmaceutical Ingredients by Region
4.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients by Region
4.1.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region
4.1.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Region
4.2 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Growth
4.3 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Growth
4.4 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Growth
4.5 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Growth

5 Americas
5.1 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country
5.1.1 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021)
5.1.2 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
5.2 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type
5.3 Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region
6.1.1 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region (2016-2021)
6.1.2 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Region (2016-2021)
6.2 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type
6.3 APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients by Country
7.1.1 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021)
7.1.2 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
7.2 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type
7.3 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients by Country
8.1.1 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
8.2 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type
8.3 Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Distributors
10.3 Antipyretic Analgesic Active Pharmaceutical Ingredients Customer

11 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Forecast
11.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Forecast by Region
11.1.1 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Forecast by Regions (2021-2026)
11.2.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Forecast by Type
11.7 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Forecast by Application

12 Key Players Analysis
12.1 Mallinckrodt Pharmaceuticals
12.1.1 Mallinckrodt Pharmaceuticals Company Information
12.1.2 Mallinckrodt Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Mallinckrodt Pharmaceuticals Main Business Overview
12.1.5 Mallinckrodt Pharmaceuticals Latest Developments
12.2 IOL
12.2.1 IOL Company Information
12.2.2 IOL Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.2.3 IOL Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 IOL Main Business Overview
12.2.5 IOL Latest Developments
12.3 Anqiu Lu’an Pharmaceutical
12.3.1 Anqiu Lu’an Pharmaceutical Company Information
12.3.2 Anqiu Lu’an Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.3.3 Anqiu Lu’an Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Anqiu Lu’an Pharmaceutical Main Business Overview
12.3.5 Anqiu Lu’an Pharmaceutical Latest Developments
12.4 Novacyl
12.4.1 Novacyl Company Information
12.4.2 Novacyl Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.4.3 Novacyl Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Novacyl Main Business Overview
12.4.5 Novacyl Latest Developments
12.5 BASF
12.5.1 BASF Company Information
12.5.2 BASF Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.5.3 BASF Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BASF Main Business Overview
12.5.5 BASF Latest Developments
12.6 Anhui BBCA Pharmaceuticals
12.6.1 Anhui BBCA Pharmaceuticals Company Information
12.6.2 Anhui BBCA Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Anhui BBCA Pharmaceuticals Main Business Overview
12.6.5 Anhui BBCA Pharmaceuticals Latest Developments
12.7 Hubei Biocause
12.7.1 Hubei Biocause Company Information
12.7.2 Hubei Biocause Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.7.3 Hubei Biocause Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hubei Biocause Main Business Overview
12.7.5 Hubei Biocause Latest Developments
12.8 Xinhua Pharm
12.8.1 Xinhua Pharm Company Information
12.8.2 Xinhua Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.8.3 Xinhua Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Xinhua Pharm Main Business Overview
12.8.5 Xinhua Pharm Latest Developments
12.9 Granules India Limited
12.9.1 Granules India Limited Company Information
12.9.2 Granules India Limited Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.9.3 Granules India Limited Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Granules India Limited Main Business Overview
12.9.5 Granules India Limited Latest Developments
12.10 Huagang Pharm
12.10.1 Huagang Pharm Company Information
12.10.2 Huagang Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.10.3 Huagang Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Huagang Pharm Main Business Overview
12.10.5 Huagang Pharm Latest Developments
12.11 Hebei Jiheng Pharmaceutical
12.11.1 Hebei Jiheng Pharmaceutical Company Information
12.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hebei Jiheng Pharmaceutical Main Business Overview
12.11.5 Hebei Jiheng Pharmaceutical Latest Developments
12.12 Zhejiang Kangle Pharmaceutical
12.12.1 Zhejiang Kangle Pharmaceutical Company Information
12.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Zhejiang Kangle Pharmaceutical Main Business Overview
12.12.5 Zhejiang Kangle Pharmaceutical Latest Developments
12.13 Jingye Group
12.13.1 Jingye Group Company Information
12.13.2 Jingye Group Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.13.3 Jingye Group Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Jingye Group Main Business Overview
12.13.5 Jingye Group Latest Developments
12.14 Hunan Zhongnan Pharmaceutical
12.14.1 Hunan Zhongnan Pharmaceutical Company Information
12.14.2 Hunan Zhongnan Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
12.14.3 Hunan Zhongnan Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Hunan Zhongnan Pharmaceutical Main Business Overview
12.14.5 Hunan Zhongnan Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Antipyretic Analgesic Active Pharmaceutical Ingredients Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Paracetamol
Table 3. Major Players of Aspirin
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Naproxen
Table 6. Major Players of Diclofenac
Table 7. Major Players of Oxaprozin
Table 8. Major Players of Dexibuprofen
Table 9. Major Players of Others
Table 10. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 11. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 12. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Type (2016-2021) & ($ million)
Table 13. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
Table 14. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Type (2016-2021)
Table 15. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 16. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 17. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Value by Application (2016-2021)
Table 18. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
Table 19. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Application (2016-2021)
Table 20. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Company (2019-2021) & (Kiloton)
Table 21. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Company (2019-2021)
Table 22. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Company (2019-2021)
Table 24. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Antipyretic Analgesic Active Pharmaceutical Ingredients Producing Area Distribution and Sales Area
Table 26. Players Antipyretic Analgesic Active Pharmaceutical Ingredients Products Offered
Table 27. Antipyretic Analgesic Active Pharmaceutical Ingredients Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region (2016-2021) (Kiloton)
Table 31. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 32. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 34. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 35. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 36. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 38. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 39. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 40. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 41. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 42. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (Kiloton)
Table 43. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 44. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 46. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 47. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 48. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 49. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 50. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 51. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 52. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 54. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 55. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 56. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 57. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 59. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 63. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 65. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 66. Key and Potential Regions of Antipyretic Analgesic Active Pharmaceutical Ingredients
Table 67. Key Application and Potential Industries of Antipyretic Analgesic Active Pharmaceutical Ingredients
Table 68. Key Challenges of Antipyretic Analgesic Active Pharmaceutical Ingredients
Table 69. Key Trends of Antipyretic Analgesic Active Pharmaceutical Ingredients
Table 70. Antipyretic Analgesic Active Pharmaceutical Ingredients Distributors List
Table 71. Antipyretic Analgesic Active Pharmaceutical Ingredients Customer List
Table 72. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Region (2021-2026) & (Kiloton)
Table 73. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Consumption Market Forecast by Region
Table 74. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2021-2026)
Table 76. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) & (Kiloton)
Table 77. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Region (2021-2026) & (Kiloton)
Table 79. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) & ($ millions)
Table 80. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) & (Kiloton)
Table 81. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) & ($ millions)
Table 82. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) & (Kiloton)
Table 83. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) & ($ millions)
Table 84. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026) & (Kiloton)
Table 85. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2021-2026)
Table 86. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 87. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2021-2026)
Table 88. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026) & (Kiloton)
Table 89. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2021-2026)
Table 90. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 91. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2021-2026)
Table 92. Mallinckrodt Pharmaceuticals Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 93. Mallinckrodt Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 94. Mallinckrodt Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 95. Mallinckrodt Pharmaceuticals Main Business
Table 96. Mallinckrodt Pharmaceuticals Latest Developments
Table 97. IOL Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 98. IOL Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 99. IOL Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 100. IOL Main Business
Table 101. IOL Latest Developments
Table 102. Anqiu Lu'an Pharmaceutical Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 103. Anqiu Lu'an Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 104. Anqiu Lu'an Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 105. Anqiu Lu'an Pharmaceutical Main Business
Table 106. Anqiu Lu'an Pharmaceutical Latest Developments
Table 107. Novacyl Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 108. Novacyl Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 109. Novacyl Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 110. Novacyl Main Business
Table 111. Novacyl Latest Developments
Table 112. BASF Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 113. BASF Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 114. BASF Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 115. BASF Main Business
Table 116. BASF Latest Developments
Table 117. Anhui BBCA Pharmaceuticals Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 118. Anhui BBCA Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 119. Anhui BBCA Pharmaceuticals Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 120. Anhui BBCA Pharmaceuticals Main Business
Table 121. Anhui BBCA Pharmaceuticals Latest Developments
Table 122. Hubei Biocause Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 123. Hubei Biocause Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 124. Hubei Biocause Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 125. Hubei Biocause Main Business
Table 126. Hubei Biocause Latest Developments
Table 127. Xinhua Pharm Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 128. Xinhua Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 129. Xinhua Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 130. Xinhua Pharm Main Business
Table 131. Xinhua Pharm Latest Developments
Table 132. Granules India Limited Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 133. Granules India Limited Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 134. Granules India Limited Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 135. Granules India Limited Main Business
Table 136. Granules India Limited Latest Developments
Table 137. Huagang Pharm Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 138. Huagang Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 139. Huagang Pharm Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 140. Huagang Pharm Main Business
Table 141. Huagang Pharm Latest Developments
Table 142. Hebei Jiheng Pharmaceutical Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 143. Hebei Jiheng Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 144. Hebei Jiheng Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 145. Hebei Jiheng Pharmaceutical Main Business
Table 146. Hebei Jiheng Pharmaceutical Latest Developments
Table 147. Zhejiang Kangle Pharmaceutical Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 148. Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 149. Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 150. Zhejiang Kangle Pharmaceutical Main Business
Table 151. Zhejiang Kangle Pharmaceutical Latest Developments
Table 152. Jingye Group Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 153. Jingye Group Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 154. Jingye Group Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 155. Jingye Group Main Business
Table 156. Jingye Group Latest Developments
Table 157. Hunan Zhongnan Pharmaceutical Basic Information, Antipyretic Analgesic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 158. Hunan Zhongnan Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Product Offered
Table 159. Hunan Zhongnan Pharmaceutical Antipyretic Analgesic Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 160. Hunan Zhongnan Pharmaceutical Main Business
Table 161. Hunan Zhongnan Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Antipyretic Analgesic Active Pharmaceutical Ingredients
Figure 2. Antipyretic Analgesic Active Pharmaceutical Ingredients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Antipyretic Analgesic Active Pharmaceutical Ingredients Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Paracetamol
Figure 10. Product Picture of Aspirin
Figure 11. Product Picture of Ibuprofen
Figure 12. Product Picture of Naproxen
Figure 13. Product Picture of Diclofenac
Figure 14. Product Picture of Oxaprozin
Figure 15. Product Picture of Dexibuprofen
Figure 16. Product Picture of Others
Figure 17. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 18. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
Figure 19. Antipyretic Analgesic Active Pharmaceutical Ingredients Consumed in Headache and Fever
Figure 20. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Headache and Fever (2016-2021) & (Kiloton)
Figure 21. Antipyretic Analgesic Active Pharmaceutical Ingredients Consumed in Cold and Cough
Figure 22. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Cold and Cough (2016-2021) & (Kiloton)
Figure 23. Antipyretic Analgesic Active Pharmaceutical Ingredients Consumed in Muscle Cramps
Figure 24. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Muscle Cramps (2016-2021) & (Kiloton)
Figure 25. Antipyretic Analgesic Active Pharmaceutical Ingredients Consumed in Others
Figure 26. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Others (2016-2021) & (Kiloton)
Figure 27. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Figure 28. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Application in 2020
Figure 29. Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Company in 2020
Figure 31. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Regions (2016-2021)
Figure 32. Global Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
Figure 33. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 34. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 35. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 36. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 37. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 38. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 40. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 41. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 42. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 43. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 44. Americas Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 45. United States Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
Figure 50. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2020
Figure 51. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 52. APAC Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 53. China Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 60. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 61. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 62. Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 63. Germany Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 72. Egypt Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Antipyretic Analgesic Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles


★調査レポート[世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年] (コード：LPI21MY0712)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアスピリン医薬品有効成分（API）市場予測 2021年-2026年
    LPI21MY0738 / LP Information / 2021年5月 / LPインフォメーション社の「アスピリン医薬品有効成分（API）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％～99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、安静時疼痛、発熱、炎症、その他などにセグメント区分してまとめました。アスピリン医薬品有効成分（API）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アスピリン医薬品有効成分（API）の世界市場概要（サマリー） ・アスピリン医薬品有効成分（API）の企業別販売量・売上 ・アスピリン医薬品有効成分（API）の企業別市場シェア ・アスピリン医薬品有効成分（API）の世界市場規模 2016年-2021年：種類別（純度（99％～99.5％）、純度（99.5％以上）、純度（99％以下）） ・アスピリン医薬品有効成分（API）の世界市場規模 2016年-2021年：用途別（安静時疼痛、発熱、炎症、その他） ・アスピリン医薬品有効成分（API）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アスピリン医薬品有効成分（API）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Aspirin Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Aspirin Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Aspirin Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Aspirin Active Pharmaceutical Ingredients...
  • 世界のパラセタモール有効成分市場予測 2021年-2026年
    LPI21MY2144 / LP Information / 2021年5月 / LPインフォメーション社の「パラセタモール有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、頭痛＆発熱、風邪＆咳、筋肉けいれん、その他などにセグメント区分してまとめました。パラセタモール有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・パラセタモール有効成分の世界市場概要（サマリー） ・パラセタモール有効成分の企業別販売量・売上 ・パラセタモール有効成分の企業別市場シェア ・パラセタモール有効成分の世界市場規模 2016年-2021年：種類別（純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）） ・パラセタモール有効成分の世界市場規模 2016年-2021年：用途別（頭痛＆発熱、風邪＆咳、筋肉けいれん、その他） ・パラセタモール有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・パラセタモール有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Paracetamol Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Paracetamol Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Paracetamol Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Paracetamol Active Pharmaceutical Ingredients...
  • 世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年
    LPI21MY9636 / LP Information / 2021年5月 / LPインフォメーション社の「高性能医薬品有効成分（HPAPI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、合成成分、生物学的成分など、用途別には、腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他などにセグメント区分してまとめました。高性能医薬品有効成分（HPAPI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高性能医薬品有効成分（HPAPI）の世界市場概要（サマリー） ・高性能医薬品有効成分（HPAPI）の企業別販売量・売上 ・高性能医薬品有効成分（HPAPI）の企業別市場シェア ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：種類別（合成成分、生物学的成分） ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：用途別（腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他） ・高性能医薬品有効成分（HPAPI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・高性能医薬品有効成分（HPAPI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of High Performance Active Pharmaceutical Ingredients (HPAPI) will have significant change from previous year. By the most conservative estimates of global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the High Performance Active Pharmaceutical Ingredients (HPAPI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...
  • 世界の農薬用有効成分市場予測 2021年-2026年
    LPI21MY0008 / LP Information / 2021年5月 / LPインフォメーション社の「農薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アセフェート、バチルスチューリンゲンシス（Bt）、ベンディオカルブ、ビフェントリン、アゾキシストロビン、ボスカリド、フルジオキソニル、1-メチルシクロプロペン、ベンジルアデニンなど、用途別には、殺虫剤、殺菌剤、除草剤、植物成長調節剤、殺鼠剤、その他などにセグメント区分してまとめました。農薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・農薬用有効成分の世界市場概要（サマリー） ・農薬用有効成分の企業別販売量・売上 ・農薬用有効成分の企業別市場シェア ・農薬用有効成分の世界市場規模 2016年-2021年：種類別（アセフェート、バチルスチューリンゲンシス（Bt）、ベンディオカルブ、ビフェントリン、アゾキシストロビン、ボスカリド、フルジオキソニル、1-メチルシクロプロペン、ベンジルアデニン） ・農薬用有効成分の世界市場規模 2016年-2021年：用途別（殺虫剤、殺菌剤、除草剤、植物成長調節剤、殺鼠剤、その他） ・農薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・農薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Agrochemical Active Ingredients will have significant change from previous year. By the most conservative estimates of global Agrochemical Active Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Agrochemical Active Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Agrochemical Active Ingredients market by product type,...
  • 世界のイブプロフェン有効成分市場予測 2021年-2026年
    LPI21MY2545 / LP Information / 2021年5月 / LPインフォメーション社の「イブプロフェン有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ラセミイブプロフェン、デキシブプロフェンなど、用途別には、大人、子供などにセグメント区分してまとめました。イブプロフェン有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イブプロフェン有効成分の世界市場概要（サマリー） ・イブプロフェン有効成分の企業別販売量・売上 ・イブプロフェン有効成分の企業別市場シェア ・イブプロフェン有効成分の世界市場規模 2016年-2021年：種類別（ラセミイブプロフェン、デキシブプロフェン） ・イブプロフェン有効成分の世界市場規模 2016年-2021年：用途別（大人、子供） ・イブプロフェン有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イブプロフェン有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Ibuprofen Active Pharmaceutical Ingredient will have significant change from previous year. By the most conservative estimates of global Ibuprofen Active Pharmaceutical Ingredient market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Ibuprofen Active Pharmaceutical Ingredient market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Ibuprofen Active Pharmaceutical Ingredient...
  • 世界の化粧品用抗炎症成分市場予測 2021年-2026年
    LPI21MY1123 / LP Information / 2021年5月 / LPインフォメーション社の「化粧品用抗炎症成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バイオベース、非バイオベースなど、用途別には、歯磨き粉、にきび製品、スキンケア製品、その他などにセグメント区分してまとめました。化粧品用抗炎症成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・化粧品用抗炎症成分の世界市場概要（サマリー） ・化粧品用抗炎症成分の企業別販売量・売上 ・化粧品用抗炎症成分の企業別市場シェア ・化粧品用抗炎症成分の世界市場規模 2016年-2021年：種類別（バイオベース、非バイオベース） ・化粧品用抗炎症成分の世界市場規模 2016年-2021年：用途別（歯磨き粉、にきび製品、スキンケア製品、その他） ・化粧品用抗炎症成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・化粧品用抗炎症成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cosmetic Anti-inflammatories Ingredients will have significant change from previous year. By the most conservative estimates of global Cosmetic Anti-inflammatories Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cosmetic Anti-inflammatories Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Anti-inflammatories Ingredients market by product type,...
  • 世界のフケ防止剤成分市場予測 2021年-2026年
    LPI21MY0698 / LP Information / 2021年5月 / LPインフォメーション社の「フケ防止剤成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、シリコーンフリー、シリコンタイプなど、用途別には、ブリーチ、染料・カラー製品、コンディショナー・デタングリング製品、ヘアジェル、シャンプー、スタイリング/ヘアフォーム、その他などにセグメント区分してまとめました。フケ防止剤成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・フケ防止剤成分の世界市場概要（サマリー） ・フケ防止剤成分の企業別販売量・売上 ・フケ防止剤成分の企業別市場シェア ・フケ防止剤成分の世界市場規模 2016年-2021年：種類別（シリコーンフリー、シリコンタイプ） ・フケ防止剤成分の世界市場規模 2016年-2021年：用途別（ブリーチ、染料・カラー製品、コンディショナー・デタングリング製品、ヘアジェル、シャンプー、スタイリング/ヘアフォーム、その他） ・フケ防止剤成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・フケ防止剤成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-dandruff Agent Ingredients will have significant change from previous year. By the most conservative estimates of global Anti-dandruff Agent Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-dandruff Agent Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-dandruff Agent Ingredients market by product type,...
  • 世界の固結防止剤成分市場予測 2021年-2026年
    LPI21MY0694 / LP Information / 2021年5月 / LPインフォメーション社の「固結防止剤成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、シリコーンフリー、シリコンタイプなど、用途別には、装飾化粧品/メイクアップ、ヘアケア、メンズケア、香水・フレグランス、スキンケア、サンケア、その他などにセグメント区分してまとめました。固結防止剤成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・固結防止剤成分の世界市場概要（サマリー） ・固結防止剤成分の企業別販売量・売上 ・固結防止剤成分の企業別市場シェア ・固結防止剤成分の世界市場規模 2016年-2021年：種類別（シリコーンフリー、シリコンタイプ） ・固結防止剤成分の世界市場規模 2016年-2021年：用途別（装飾化粧品/メイクアップ、ヘアケア、メンズケア、香水・フレグランス、スキンケア、サンケア、その他） ・固結防止剤成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・固結防止剤成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-caking Agent Ingredients will have significant change from previous year. By the most conservative estimates of global Anti-caking Agent Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-caking Agent Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-caking Agent Ingredients market by product type,...
  • 世界のアルファルファ濃縮飼料添加物市場予測 2021年-2026年
    LPI21MY0607 / LP Information / 2021年5月 / LPインフォメーション社の「アルファルファ濃縮飼料添加物の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アルファルファ濃縮粉末、アルファルファ濃縮ペレット、その他など、用途別には、ペット・馬・小動物、養殖、その他などにセグメント区分してまとめました。アルファルファ濃縮飼料添加物のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アルファルファ濃縮飼料添加物の世界市場概要（サマリー） ・アルファルファ濃縮飼料添加物の企業別販売量・売上 ・アルファルファ濃縮飼料添加物の企業別市場シェア ・アルファルファ濃縮飼料添加物の世界市場規模 2016年-2021年：種類別（アルファルファ濃縮粉末、アルファルファ濃縮ペレット、その他） ・アルファルファ濃縮飼料添加物の世界市場規模 2016年-2021年：用途別（ペット・馬・小動物、養殖、その他） ・アルファルファ濃縮飼料添加物の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アルファルファ濃縮飼料添加物のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Alfalfa Concentrate Feed Additive will have significant change from previous year. By the most conservative estimates of global Alfalfa Concentrate Feed Additive market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Alfalfa Concentrate Feed Additive market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Alfalfa Concentrate Feed Additive...
  • 世界の女性用アクティブウェア市場予測 2021年-2026年
    LPI21MY4323 / LP Information / 2021年5月 / LPインフォメーション社の「女性用アクティブウェアの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、Tシャツ、スウェットパンツ＆ヨガパンツ、スカート＆スコート、トラックスーツ、スウェットシャツ、その他など、用途別には、スーパーマーケット、専門店、オンライン小売店、その他などにセグメント区分してまとめました。女性用アクティブウェアのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・女性用アクティブウェアの世界市場概要（サマリー） ・女性用アクティブウェアの企業別販売量・売上 ・女性用アクティブウェアの企業別市場シェア ・女性用アクティブウェアの世界市場規模 2016年-2021年：種類別（Tシャツ、スウェットパンツ＆ヨガパンツ、スカート＆スコート、トラックスーツ、スウェットシャツ、その他） ・女性用アクティブウェアの世界市場規模 2016年-2021年：用途別（スーパーマーケット、専門店、オンライン小売店、その他） ・女性用アクティブウェアの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・女性用アクティブウェアのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Women Active Wear will have significant change from previous year. By the most conservative estimates of global Women Active Wear market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Women Active Wear market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Women Active Wear market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆